S07826 Summary:

BILL NOS07826
 
SAME ASNo Same As
 
SPONSORKENNEDY
 
COSPNSR
 
MLTSPNSR
 
Amd §§3216, 3221 & 4303, Ins L
 
Relates to requiring prescription drug coverage to include such supplements and vitamins, medical foods, and other medications as shall be deemed necessary by a physician to mitigate and/or treat the symptoms of mitochondrial disease.
Go to top    

S07826 Actions:

BILL NOS07826
 
03/01/2018REFERRED TO INSURANCE
Go to top

S07826 Committee Votes:

Go to top

S07826 Floor Votes:

There are no votes for this bill in this legislative session.
Go to top

S07826 Text:



 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                          7826
 
                    IN SENATE
 
                                      March 1, 2018
                                       ___________
 
        Introduced  by  Sen. KENNEDY -- read twice and ordered printed, and when
          printed to be committed to the Committee on Insurance
 
        AN ACT to amend the insurance law, in relation to requiring prescription
          drug coverage to include such supplements and vitamins, medical foods,
          and other medications as shall be deemed necessary to mitigate  and/or
          treat the symptoms of mitochondrial disease

          The  People of the State of New York, represented in Senate and Assem-
        bly, do enact as follows:
 
     1    Section 1. Subsection (i) of section 3216  of  the  insurance  law  is
     2  amended by adding a new paragraph 34 to read as follows:
     3    (34)  (A)  Every policy which provides coverage for prescription drugs
     4  shall include coverage for the cost of such  supplements  and  vitamins,
     5  medical  foods, and other medications used to treat the symptoms associ-
     6  ated with mitochondrial disease as a physician shall deem  necessary  to
     7  mitigate  and/or  treat the symptoms of such mitochondrial disease diag-
     8  nosed through clinical assessment, muscle biopsy, biochemical testing or
     9  genetic testing in a covered person.
    10    (B) Such coverage may be subject to such annual deductibles and  coin-
    11  surance  as  may  be deemed appropriate by the superintendent and as are
    12  consistent with those established for other benefits within the policy.
    13    § 2. Subsection (k) of section 3221 of the insurance law is amended by
    14  adding a new paragraph 22 to read as follows:
    15    (22) (A) Every group or blanket policy delivered or issued for  deliv-
    16  ery  in  this  state that provides coverage for prescription drugs shall
    17  include coverage for the cost of such supplements and vitamins,  medical
    18  foods,  and other medications used to treat the symptoms associated with
    19  mitochondrial disease as a physician shall deem  necessary  to  mitigate
    20  and/or  treat  the  symptoms  of  such  mitochondrial  disease diagnosed
    21  through clinical  assessment,  muscle  biopsy,  biochemical  testing  or
    22  genetic testing in a covered person.
    23    (B)  Such coverage may be subject to such annual deductibles and coin-
    24  surance as may be deemed appropriate by the superintendent  and  as  are
    25  consistent with those established for other benefits within the policy.
 
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD14787-01-8

        S. 7826                             2
 
     1    §  3.  Section  4303  of  the insurance law is amended by adding a new
     2  subsection (oo) to read as follows:
     3    (oo)  (1)  Every  contract  issued  by  a  corporation  subject to the
     4  provisions of this article  which  provides  coverage  for  prescription
     5  drugs  shall include coverage for the cost of such supplements and vita-
     6  mins, medical foods, and other medications used to  treat  the  symptoms
     7  associated  with  mitochondrial disease as a physician shall deem neces-
     8  sary to mitigate and/or treat the symptoms of such mitochondrial disease
     9  diagnosed through clinical assessment, muscle biopsy, biochemical  test-
    10  ing or genetic testing in a covered person.
    11    (2)  Such coverage may be subject to such annual deductibles and coin-
    12  surance as may be deemed appropriate by the superintendent  and  as  are
    13  consistent   with  those  established  for  other  benefits  within  the
    14  contract.
    15    § 4. This act shall take effect on the first of January next  succeed-
    16  ing  the  date  on  which  it shall have become a law and shall apply to
    17  policies and contracts issued, reissued, renewed, modified or amended on
    18  or after such date.
Go to top